Japan pledges $2 billion in funding for pandemic vaccine research initiative




 

The Japanese government has earmarked $2 billion in funding for vaccine research in an effort to make sure its country is better prepared for any future pandemic, according to Nature. Japan lagged behind other countries not just in developing vaccines, but also in approving them when it came to COVID-19. As the publication points out, three of Japan's most advanced COVID-19 vaccine candidates are still undergoing clinical trials. To prevent a repeat, the country established the Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA) back in March.

SCARDA's central research center will be based in Tokyo, but it will be supported by four core institutes, namely Osaka University, Nagasaki University, Hokkaido University and Chiba University. The $2 billion funding is supposed to keep it running for five years. $1.2 billion will go towards the center's vaccine research and development projects, while $400 million will be spent on supporting start-ups in drug development. The other $400 million will go towards setting up a network of research centers across the nation, as well as towards vaccine testing.

SCARDA will initially focus on developing vaccines for eight infectious diseases, including COVID-19, monkeypox, SARS, dengue and Zika virus. Its researchers will look into various types of vaccine technologies, as well, such as mRNA and viral vectors. The center aims "to find seeds for future vaccines," but its ultimate goal is to be able to conjure up diagnostic tests, vaccines and treatments within 100 days of the identification of a pathogen that has the potential to become a pandemic.

It was the UK government that first proposed the 100-day response goal, based on what it learned from COVID-19. "The first 100 days when faced with a pandemic or epidemic threat are crucial to changing its course and, ideally, preventing it from becoming a pandemic," the UK wrote in its pandemic preparedness report to the G7. According to the World Health Organization, it recorded over 2.5 million cases and 200,000 deaths 100 days after it declared COVID-19 as a public health emergency of international concern. A swift response from the start could've prevented those numbers from getting any higher.

COMMENTS

More Related News

Asian shares rise except Japan as markets eye China protests
Asian shares rise except Japan as markets eye China protests
  • US
  • 2022-11-29 05:44:09Z

Asian shares were mostly higher Tuesday as jitters over protests in China set off by growing public anger over COVID-19 restrictions subsided. Oil prices...

Asia shares take comfort in China property rally
Asia shares take comfort in China property rally

Asian shares edged higher on Tuesday as Beijing's latest move to support developers boosted the property sector, though it was still not clear what new...

Japan births at new low as population shrinks and ages
Japan births at new low as population shrinks and ages
  • US
  • 2022-11-28 10:10:18Z

The number of babies born in Japan this year is below last year's record low in what the the top government spokesman described as a "critical situation...

Japan
Japan's Kishida rules out changing policy agreement with BOJ
  • US
  • 2022-11-28 01:55:14Z

TOKYO (Reuters) -Japanese Prime Minister Fumio Kishida on Monday brushed aside the chance of adding wage growth as a new monetary policy goal the government ...

Stocks, oil skid as China
Stocks, oil skid as China's COVID protests roil sentiment
  • US
  • 2022-11-28 00:54:45Z

Stocks and oil slid sharply on Monday as rare protests in major Chinese cities against the country's strict zero-COVID curbs raised worries about management ...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Economy